Literature DB >> 6439007

Dose-response curve for the ergotamine-induced decrease of peripheral systolic blood pressure in man.

P Tfelt-Hansen, P M Manniche.   

Abstract

Ergotamine tartrate (approximately 0.05, 0.125, 0.25 and 0.5 mg per 70 kg body weight) was given intravenously to 5 volunteers in a double-blind cross-over study. For 6 hours the following parameter were studied: arm, ankle and big toe systolic blood pressures. A dose-dependent but transient increase of arm systolic blood pressure was found. For changes of ankle-arm systolic gradients no dose-response curve could be established. Toe-arm systolic gradients showed a dose-dependent decrease, which at 4 to 6 hours seems suitable for pharmacodynamic comparison of different doses or routes of administration of ergotamine tartrate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439007     DOI: 10.1111/j.1600-0773.1984.tb02043.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  2 in total

1.  The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects.

Authors:  Peer Tfelt-Hansen; Kaj Seidelin; Michael Stepanavage; Christopher Lines
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 2.  A review of current drugs for migraine.

Authors:  J Olesen
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.